Makenzie Canaday 
Growth Supports Tekton’s Strategic Focus in CNS and Cardiometabolic Research AUSTIN, TX – October 2, 2025 — Tekton Research, a leading multi-site clinical trial company, is pleased to announce the promotion of Corey A. Collins to Chief Executive Officer (CEO). Collins joined Tekton in December 2023 as Chief Financial Officer, bringing over 20 years of … Read more
Growth supports Tekton’s strategic focus on CNS and Cardiometabolic research AUSTIN, TX – September 26, 2025 — Tekton Research, a leading multi-site clinical trial company, is proud to announce the addition of three new sites, five new Principal Investigators (PIs), and a renowned CNS Consultant to its expanding network. These additions reflect Tekton’s continued commitment … Read more
When it comes to clinical research, no two studies are exactly alike—but rare disease trials stand in a category of their own. Though each condition may affect only a small number of people, together rare diseases impact an estimated 300 million patients worldwide. For these individuals and families, research often represents the only pathway to … Read more
Alzheimer’s Disease remains one of the most pressing public health challenges of our time. Affecting over 6 million Americans, this progressive neurological disorder not only takes a profound toll on individuals and their families–it also places a significant burden on healthcare systems worldwide. While there is no cure yet, hope is on the horizon–and clinical … Read more
Obesity is more than a number on a scale–it’s a chronic disease that significantly increases the risk of developing long-term health conditions. At Tekton Research, we’re committed to advancing research in obesity because we know it’s at the core of a larger health crisis. Understanding and treating obesity isn’t just about weight loss, it’s about … Read more
Clinical trials are essential to advancing medicine, bringing new therapies from discovery to approval. Traditionally, these trials have been centered in academic institutions and large hospitals—but embedded research site networks like Tekton help make trials accessible within community-based settings, where patients are being treated every day. As a trusted partner in clinical research, Tekton makes … Read more
In today’s healthcare landscape, health literacy is more than a buzzword—it’s a foundational element for equitable, ethical, and effective clinical research. But what does health literacy really mean, and why is it so vital in the research setting? Defining Health Literacy Health literacy refers to a person’s ability to access, understand, and use information to … Read more
Overview Tekton Research played a pivotal role in advancing a recent Alzheimer’s Disease clinical trial, demonstrating exceptional performance across enrollment, site readiness, and strategic consultation. Our team not only enrolled the study’s first patient but also exceeded initial recruitment expectations, delivering high-quality data while supporting a newly engaged Principal Investigator (PI) through our robust training … Read more
Midlothian, VA — Tekton Research is proud to welcome Ben Phillips, MD, a board-certified endocrinologist and leader in diabetes, obesity, and osteoporosis care, as a Principal Investigator. This partnership expands Tekton’s clinical research footprint into the Midlothian and Richmond, Virginia region. With over 25 years of clinical experience, Dr. Phillips brings deep expertise in treating … Read more
Each year on May 20, we pause to honor Clinical Trials Day–a global recognition of the people, partnerships and progress that make clinical research possible. This day marks the anniversary of the first randomized clinical trial, conducted in 1747 by James Lind, and serves as a moment to reflect on how far we’ve come–and where … Read more